Genomics and Proteomic Tools - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511244432

Publication Date:

November 4, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Genomics and Proteomic Tools was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Genomics and Proteomic Tools was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Genomics and Proteomic Tools was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Genomics and Proteomic Tools was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Genomics and Proteomic Tools include 3Billion Inc., Bio-Rad Laboratories Inc., GE Healthcare, Novogene Corp., Qiagen NV and Waters Corp., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Genomics and Proteomic Tools, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Genomics and Proteomic Tools by region & country, by Type, and by Application.
The Genomics and Proteomic Tools market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomics and Proteomic Tools.
Market Segmentation
By Company
3Billion Inc.
Bio-Rad Laboratories Inc.
GE Healthcare
Novogene Corp.
Qiagen NV
Waters Corp.
Segment by Type:
Sample Preparation
Electrophoresis
BioChips and Microarrays
Chromatography
Mass Spectrometry
Thermal Cyclers
Next-Gen Sequencing
Segment by Application
Agriculture and Animal Husbandry
Drug Discovery
Forensics
Proteogenomics Research
Disease Identification, Diagnostics and Control
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Genomics and Proteomic Tools manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Genomics and Proteomic Tools in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Genomics and Proteomic Tools in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Genomics and Proteomic Tools Product Introduction
1.2 Global Genomics and Proteomic Tools Market Size Forecast
1.3 Genomics and Proteomic Tools Market Trends & Drivers
1.3.1 Genomics and Proteomic Tools Industry Trends
1.3.2 Genomics and Proteomic Tools Market Drivers & Opportunity
1.3.3 Genomics and Proteomic Tools Market Challenges
1.3.4 Genomics and Proteomic Tools Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Genomics and Proteomic Tools Players Revenue Ranking (2023)
2.2 Global Genomics and Proteomic Tools Revenue by Company (2019-2024)
2.3 Key Companies Genomics and Proteomic Tools Manufacturing Base Distribution and Headquarters
2.4 Key Companies Genomics and Proteomic Tools Product Offered
2.5 Key Companies Time to Begin Mass Production of Genomics and Proteomic Tools
2.6 Genomics and Proteomic Tools Market Competitive Analysis
2.6.1 Genomics and Proteomic Tools Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Genomics and Proteomic Tools Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics and Proteomic Tools as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Sample Preparation
3.1.2 Electrophoresis
3.1.3 BioChips and Microarrays
3.1.4 Chromatography
3.1.5 Mass Spectrometry
3.1.6 Thermal Cyclers
3.1.7 Next-Gen Sequencing
3.2 Global Genomics and Proteomic Tools Sales Value by Type
3.2.1 Global Genomics and Proteomic Tools Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Genomics and Proteomic Tools Sales Value, by Type (2019-2030)
3.2.3 Global Genomics and Proteomic Tools Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Agriculture and Animal Husbandry
4.1.2 Drug Discovery
4.1.3 Forensics
4.1.4 Proteogenomics Research
4.1.5 Disease Identification, Diagnostics and Control
4.2 Global Genomics and Proteomic Tools Sales Value by Application
4.2.1 Global Genomics and Proteomic Tools Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Genomics and Proteomic Tools Sales Value, by Application (2019-2030)
4.2.3 Global Genomics and Proteomic Tools Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Genomics and Proteomic Tools Sales Value by Region
5.1.1 Global Genomics and Proteomic Tools Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Genomics and Proteomic Tools Sales Value by Region (2019-2024)
5.1.3 Global Genomics and Proteomic Tools Sales Value by Region (2025-2030)
5.1.4 Global Genomics and Proteomic Tools Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Genomics and Proteomic Tools Sales Value, 2019-2030
5.2.2 North America Genomics and Proteomic Tools Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Genomics and Proteomic Tools Sales Value, 2019-2030
5.3.2 Europe Genomics and Proteomic Tools Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Genomics and Proteomic Tools Sales Value, 2019-2030
5.4.2 Asia Pacific Genomics and Proteomic Tools Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Genomics and Proteomic Tools Sales Value, 2019-2030
5.5.2 South America Genomics and Proteomic Tools Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Genomics and Proteomic Tools Sales Value, 2019-2030
5.6.2 Middle East & Africa Genomics and Proteomic Tools Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Genomics and Proteomic Tools Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Genomics and Proteomic Tools Sales Value
6.3 United States
6.3.1 United States Genomics and Proteomic Tools Sales Value, 2019-2030
6.3.2 United States Genomics and Proteomic Tools Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Genomics and Proteomic Tools Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Genomics and Proteomic Tools Sales Value, 2019-2030
6.4.2 Europe Genomics and Proteomic Tools Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Genomics and Proteomic Tools Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Genomics and Proteomic Tools Sales Value, 2019-2030
6.5.2 China Genomics and Proteomic Tools Sales Value by Type (%), 2023 VS 2030
6.5.3 China Genomics and Proteomic Tools Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Genomics and Proteomic Tools Sales Value, 2019-2030
6.6.2 Japan Genomics and Proteomic Tools Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Genomics and Proteomic Tools Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Genomics and Proteomic Tools Sales Value, 2019-2030
6.7.2 South Korea Genomics and Proteomic Tools Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Genomics and Proteomic Tools Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Genomics and Proteomic Tools Sales Value, 2019-2030
6.8.2 Southeast Asia Genomics and Proteomic Tools Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Genomics and Proteomic Tools Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Genomics and Proteomic Tools Sales Value, 2019-2030
6.9.2 India Genomics and Proteomic Tools Sales Value by Type (%), 2023 VS 2030
6.9.3 India Genomics and Proteomic Tools Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 3Billion Inc.
7.1.1 3Billion Inc. Profile
7.1.2 3Billion Inc. Main Business
7.1.3 3Billion Inc. Genomics and Proteomic Tools Products, Services and Solutions
7.1.4 3Billion Inc. Genomics and Proteomic Tools Revenue (US$ Million) & (2019-2024)
7.1.5 3Billion Inc. Recent Developments
7.2 Bio-Rad Laboratories Inc.
7.2.1 Bio-Rad Laboratories Inc. Profile
7.2.2 Bio-Rad Laboratories Inc. Main Business
7.2.3 Bio-Rad Laboratories Inc. Genomics and Proteomic Tools Products, Services and Solutions
7.2.4 Bio-Rad Laboratories Inc. Genomics and Proteomic Tools Revenue (US$ Million) & (2019-2024)
7.2.5 Bio-Rad Laboratories Inc. Recent Developments
7.3 GE Healthcare
7.3.1 GE Healthcare Profile
7.3.2 GE Healthcare Main Business
7.3.3 GE Healthcare Genomics and Proteomic Tools Products, Services and Solutions
7.3.4 GE Healthcare Genomics and Proteomic Tools Revenue (US$ Million) & (2019-2024)
7.3.5 Novogene Corp. Recent Developments
7.4 Novogene Corp.
7.4.1 Novogene Corp. Profile
7.4.2 Novogene Corp. Main Business
7.4.3 Novogene Corp. Genomics and Proteomic Tools Products, Services and Solutions
7.4.4 Novogene Corp. Genomics and Proteomic Tools Revenue (US$ Million) & (2019-2024)
7.4.5 Novogene Corp. Recent Developments
7.5 Qiagen NV
7.5.1 Qiagen NV Profile
7.5.2 Qiagen NV Main Business
7.5.3 Qiagen NV Genomics and Proteomic Tools Products, Services and Solutions
7.5.4 Qiagen NV Genomics and Proteomic Tools Revenue (US$ Million) & (2019-2024)
7.5.5 Qiagen NV Recent Developments
7.6 Waters Corp.
7.6.1 Waters Corp. Profile
7.6.2 Waters Corp. Main Business
7.6.3 Waters Corp. Genomics and Proteomic Tools Products, Services and Solutions
7.6.4 Waters Corp. Genomics and Proteomic Tools Revenue (US$ Million) & (2019-2024)
7.6.5 Waters Corp. Recent Developments
8 Industry Chain Analysis
8.1 Genomics and Proteomic Tools Industrial Chain
8.2 Genomics and Proteomic Tools Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Genomics and Proteomic Tools Sales Model
8.5.2 Sales Channel
8.5.3 Genomics and Proteomic Tools Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

3Billion Inc.
Bio-Rad Laboratories Inc.
GE Healthcare
Novogene Corp.
Qiagen NV
Waters Corp.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂